NDRA Nilai Total Aset Perusahaan ENDRA Life Sciences Inc

This price chart for ENDRA Life Sciences (NDRA), where total assets equal 5.38, assists in the basic asset valuation and shows a company facing pressure from medtech giants implementing software updates for legacy equipment. The business relies on promoting affordable ultrasound scanning as a replacement for costly MRI screening. Market capitalization growth is driven by FDA approvals and the scaling of clinic networks, which validate the market value of the TAEUS system.

This indicator reflects the total resource value of ENDRA Life Sciences (NDRA), calculated inversely via ROA as the sum of liabilities and equity, allowing for an assessment of the business's actual scale without market noise. The trend in consolidated assets confirms the capitalization of innovations in TAEUS technology for affordable liver diagnostics, where a growing resource base coupled with controlled debt signals a fundamental strengthening of NDRA's position.